HealthcareUnitedHealthcare to limit Aduhelm access

UnitedHealthcare to limit Aduhelm access

UnitedHealthcare will restrict coverage of Biogen’s Aduhelm, the nation’s largest health insurance company notified providers Sunday.

The UnitedHealth Group subsidiary will only cover the costly Alzheimer’s disease treatment also known as aducanumab for patients enrolled in clinical trials and will require prior authorization. The medication is “unproven and not medically necessary for the treatment of Alzheimer’s disease due to insufficient evidence of efficacy,” the insurer wrote in bulletins sent to providers.

The rules apply to the insurer’s commercial, individual and Medicare members and take effect June 1.

The company’s policy aligns with the Centers for Medicare and Medicaid Services’s recent decision to limit Aduhelm coverage to Medicare beneficiaries participating in clinical trials. Under federal law, Medicaid must cover virtually all prescription drugs that the Food and Drug Administration approves, including Aduhelm. States may impose limits such as requiring prior authorization, CMS determined.

UnitedHealthcare cited a number of studies to support its decision, including a July report by the Institute for Clinical and Economic Review that concluded patient use of the drug with supportive care did not produce a net health benefit compared to supportive care alone.

“We will continue to monitor ongoing clinical studies, as well as guidance from CMS and other agencies, and will update our clinical and coverage policies as necessary,” UnitedHealthcare said in a statement.

UnitedHealthcare is the first publicly traded health insurer to announce an Aduhelm coverage decision. Other carriers, including at least six not-for-profit Blue Cross and Blue Shield affiliates, are not covering Aduhelm. In addition, major providers such as Mount Sinai Health System and the Cleveland Clinic won’t prescribe the medicine.

Original Source Link


Please enter your comment!
Please enter your name here

Latest News

Carvana offers first-quarter guidance, restructures debt

A Carvana glass tower sits illuminated on Feb. 23, 2022, in Oak Brook, Illinois.Armando L. Sanchez | Tribune...

‘Get comfortable with discomfort’ for Web3 success: PBW 2023

The metaverse continues to be a hot topic in the Web3 space, with a group of industry professionals...

Federal Reserve set for pivotal decision on interest rates amid bank turmoil

The US Federal Reserve is on Wednesday set to make a pivotal decision on whether to press ahead...

Travelrest Nest Ultimate Travel Pillow: Neck Support for Great Sleep

Throughout my life, I’ve tried a bunch of U-shaped travel pillows—the ones that go around your neck—and frankly,...

H&H Group delivers revenue growth across all three business segments for 2022 and expects positive outlook for 2023

• Reported revenue growth of 10.6% with revenue of RMB12,775.9 million and adjusted EBITDA growth of 6.5% despite...

As Trump Awaits Criminal Charges, Biden Hangs Out With Bruce Springsteen

As Donald Trump awaits criminal charges in Manhattan, President Joe Biden is spending his day hanging out with...

Must Read

Donald Trump may finally face an indictment

For 40 years, former President Donald Trump has navigated countless...
- Advertisement -

You might also likeRELATED
Recommended to you